Scotland · NHS Scotland MSAN
Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tablets
MSAN(2026)25 · Level 2 · issued 24 Jul 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Tensipine® MR 10 and 20 tablets will be out of stock from early August 2026 and early | Out of stock | — |
| October 2026 respectively. The resupply dates for both strengths are to be confirmed. | Resupply date to be confirmed | — |
| Adalat® LA 30 tablets are out of stock from late July 2026 until late November 2026. | Out of stock | late November 2026 |
| Adanif® XL 30mg and 60mg tablets have been discontinued. | Discontinued | — |
| Alternative brands of nifedipine modified-release tablets remain available and can support | Available | — |
| remain available and can support increased demand. | Available | — |
| have resolved noting that Adanif® XL products have been discontinued, and ensuring patients | Discontinued | — |
| tablets to last until the re-supply date, or are currently prescribed the discontinued Adanif® XL | Discontinued | the re-supply date |
| 2026 as this product can support a partial uplift in demand. | Available — partial uplift only | — |
| supply date, or are currently prescribed the discontinued Adanif® XL 60mg tablets (both once | Discontinued | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.